‘Tepid’ response to CRISPR embryo editing could lead to regulations, Gottlieb says

The scientific community’s response to reports of human germline editing by Chinese researcher Jiankui He has been too little and too late, and governments may respond with heavy handed regulations, FDA Commissioner Scott Gottlieb told BioCentury. NIH Director Francis Collins released a statement calling for a binding international consensus on limits for such research.

“Governments will now have to react, and that reaction may have to take consideration of the fact that the scientific community failed to convincingly assert, in this case, that certain conduct must simply be judged as over the line,” Gottlieb said...